Introduction
The outbreaks of infections caused by antibiotic-resistant microbial pathogens are costly and may possibly become lethal. The emergence and outbreaks of antibioticresistant bacteria are a worldwide hazard to both humans and animals and are commonly uncontrollable. 1, 2 The discovery of antimicrobial agents is not a routine procedure, and resistance has developed to most antibiotics, regardless of their chemical characteristics or molecular targets. 3 The management of the global challenge of antimicrobial resistance needs a decrease in antibiotic administration to decrease the choice pressure, an efficient infection control strategy to reduce the spread of resistant organisms, and novel antimicrobial drugs. 4 New agents to reach clinical practice are reactive oxygen species (ROS), which have antimicrobial activity. ROS have an effective antimicrobial action against a wide spectrum of pathogens. ROS are effective in vitro against most Gram-positive and Gram-negative organisms, including multidrug-resistant isolates which are causing infection control and therapeutic problems. 5 The term "ROS" refers to reactive radicals, including superoxide anion ( 
ions that are constantly harvested as side products of some cell biologic process. 5, 6 The use of ROS is a new therapeutic approach for topical use on skin, mucosal membranes, or internal tissue that may be colonized with microbial inhabitants and biofilms. 7 This study presents an overview of ROS formation and the use of ROS-dependent procedures for antimicrobial therapy.
Molecular oxygen (O 2 ) is used by aerobic organisms for respiration and for the oxidation of metabolites to acquire energy. 8 It is a nonpolar small molecule that diffuses quickly across typical biologic membranes through water. 9 After entering the microbes, environmental O 2 interacts with the cellular structure and uses it for adenosine triphosphate generation during the process of oxidative phosphorylation. This process is associated with the reduction process of O 2 to water, and it is the central mechanism providing energy to aerobic organisms. 10 The interactions between O 2 and biologic molecules, especially respiratory flavoenzymes, are associated with ROS formation (Figure 1 
Oxidative stress in bacteria
ROS are constantly generated as secondary metabolites of some biologic processes and from certain cell procedures under delicate control. Simultaneously, reactions involving ROS are catalyzed by some specific or nonspecific reactions. Two dissimilar procedures, the production and the elimination of ROS, are normally controlled by fine cellular mechanisms, and the stable level of ROS are present in the cells. 13 However, under certain conditions, the equilibrium between ROS generation and degradation is disturbed as a result of their increased concentration, referred to as oxidative stress.
14 Under these circumstances and under normal conditions, the free radicals produced can change all types of biologic molecules that, if not taken up, accumulate in the cell. 10 Several chemical and physical factors can lead to increase in ROS levels to a threshold that exceeds the cellular tolerance and, thereby, oxidative stress. Certain immune cells also stimulate oxidative stress by expressing NADPH oxidase and myeloperoxidase, upon the phagocytosis of invasive bacteria, as a defense mechanism. 8 Heat shock, ionizing radiation, and ultraviolet radiation induce the generation of extremely injurious free radicals due to different mechanisms that cause oxidative stress. 15, 16 Oxidative stress is involved in the antibacterial mechanisms of some antibiotics such as quinolones, β-lactams, and aminoglycosides that motivate OH
• generation through the Fenton reaction. 17, 18 Engineered nanoparticles induce oxidative stress in cells by producing reactive radicals at or near their surface. 19, 20 The biologic targets of ROS 
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Antimicrobial use of reactive oxygen therapy to biomolecules, OH • formation can occur in the DNA, proteins, and lipids in the immediate vicinity, thereby causing its damaging effect. Fe 2+ shows a sequence-specific affinity when interacting with DNA and contributing to the Fenton reaction. The cellular targets for the toxic effects of ROS are DNA, RNA, proteins, and lipids. 21 Most of the destruction is triggered by the OH produced by the Fenton reaction, which needs iron (or an alternative divalent metal ion) and reducing agent (such as NADH). A reducing agent is essential for reproduction of iron or alternative divalent metal ion. 8 The antimicrobial effects of ROS are directly prompted by interaction with the thiol groups in proteins, DNA, and cell membranes through a dose-dependent effect. 4 DNA is the main target in H 2 O 2 -dependent cytotoxicity in an interaction that affects the bases of DNA or damages it by breaking up the deoxyribose structure. ROS induce physical destruction in incorporated or free nucleotides; in addition, they break single-or double-stranded DNA in the double helix. Moreover, DNA can be broken by the by-products of lipid peroxidation. 22, 23 The RGGG sequences and RTGR sites are the most nicked at 10-50 and 0.05-2.5 mM of H 2 O 2 , respectively. 24 The effect at lower levels of H 2 O 2 is represented as Mode I, while that at higher H 2 O 2 levels is denoted as Mode II. 25 ROS or free radicals induce direct damage to lipids at high concentrations. The destructive OH
• can promote the peroxidation of lipids and can trigger the chain oxidation of polyunsaturated phospholipids of the cell membranes, consequently resulting in their reduced functions. 26 Damage induced by ROS to the bacterial cell membrane differs from that caused to eukaryotes because of the absence of polyunsaturated phospholipids in the membrane of most prokaryotes. 27 Peroxidation of lipids has been demonstrated after phagocytosis of bacteria by the neutrophils, but it is not recognized whether it is associated with or induces bacterial killing. 28 ROS can cause disruption in the membrane lipid bilayer organization that may deactivate membrane-located receptors and proteins, eventually leading to cell fluidity, efflux of cytosolic contents, and the defeat of membrane-functions. 27, 29 Proteins are also a main biologic target of ROS. Different types of damage are recognized, such as oxidation of sulfhydryl groups, reduction of disulfides, oxidative adduction of amino acid residues near to metal-binding locations through metal-dependent oxidation, interaction with aldehydes, alteration of prosthetic groups or metal clusters, protein-protein cross-linking, and peptide breakup. 8 Proteins can be subjected to a variety of specific oxidative alterations at cysteine, methionine, tyrosine, phenylalanine, and tryptophan residues. Protein carbonyls that are generated by the oxidative reaction of arginine, proline, or lysine are detectable following oxidative damage. H 2 O 2 can cause oxidative modifications in proteins, such as elongation factor G, DnaK, alcohol dehydrogenase E, enolase, OppA, OmpA, and the F0F1-ATPase of Escherichia coli.
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Cellular defense mechanisms against ROS
The cellar defenses against ROS can be summarized into three chief mechanisms: 1) suspension of ROS formation; 2) suppression of chain propagation; and 3) repair of damage. 10 Due to their simplicity compared to eukaryotes, prokaryotes have been generally used as a model to investigate and describe the processes of ROS generation and oxidative stress effects on cells. 31 •− , respectively, in E. coli. 31, 32 Several bacterial pathogens prevent the increase of ROS by directly inhibiting the synthesis of NADPH oxidase. In these cases, organisms generally inhibit the recruitment of critical subunits to the phagosome or NADPH oxidase, thus decreasing the induction of oxidative stress conditions in neutrophils. [33] [34] [35] The OxyR and the SoxRS systems When bacteria are exposed to high levels of H 2 O 2 , oxidative stress may occur. This condition is identified as a transcription factor referred to as OxyR, which responds rapidly to H 2 O 2 through an active site containing a conserved cysteine residue. It is typically inactive during aerobic conditions when the cellular concentration of H 2 O 2 is ~50 nM. However, a cellular level of ~200 nM H 2 O 2 is adequate to stimulate OxyR into a disulfide-bonded type that actively induces the expression of a dozen operons around the chromosome. OxyR exists in oxidized or reduced forms which bind to DNA at different specific binding sites. This different specific binding to DNA allows OxyR to activate under different cellular circumstances. During oxidative stress, OxyR increases the expression of katG and ahpC genes by inducing the binding of RNA polymerase to the promoter. 36 OxyR stimulates the production of catalase G and alkyl hydroxyperoxide reductase up to 10- 37 PerR controls many of the same homologous genes' enzymes that OxyR controls. 38 The details of the H 2 O 2 -sensing mechanisms of this distinct regulation are unknown. 9, 39 In contrast to H 2 O 2 , O 2 − is a charged molecule at normal pH and it cannot traverse the cell membranes. SoxR is another system that responds primarily to O 2 − under conditions of oxidative stress. 40 SoxR contains a 2Fe-2S cluster, which is oxidized under oxidative stress and activates SoxR. Activated SoxR stimulates the production of SoxS, which then motivates the expression of its target gene. These genes may be involved in eliminating oxidative agents, repairing systems of affected biomolecules and maintaining normal cellular physiologic circumstances.
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ROS formation induced by metal nanoparticles
The application of nanomaterials in clinical microbiology has gained significant attention in the field of chemotherapy because of their direct antimicrobial effects or as delivery systems. [43] [44] [45] [46] [47] [48] [49] [50] [51] Oxidative stress due to ROS formation is the chief mechanism of the antibacterial affectivity. 19, 51, 52 The potential of ROS production due to conversion of hydrogen peroxide by a Fentonlike pathway was described for metal nanoparticles. 53, 54 A multifunctional nanoparticle system was demonstrated for the simultaneous inhibition of catalase and induction of ROS production. 55 This system can increase the sensitivity of biologic targets to the lethal effects of ROS. The toxic effects of different nanomaterials mediated by the formation of ROS have been reported in several biologic models, including human skin fibroblasts, erythrocytes, macrophages, keratinocytes, and monocytes. 56 Engineered nanomaterials possess a small size, high specific surface area, and high surface reactivity, leading to the production of higher levels of ROS and resulting in cytotoxicity and genotoxicity. 56, 57 The photogeneration of ROS on the surfaces of metal-oxide nanoparticles has been investigated in several studies. 36, 51, 58 The general principle of photogeneration is the absorption of a light having equivalent or greater energy than the band gap which prompts the electrons (e − ) of the nanoparticles. The transfer of exited e − across the band gap to the conduction band creates a hole (h + ) in the valence band that exhibits significant oxidizing activity. 51 The interaction between molecular O 2 and these electrons can induce O 2
•− formation through a reduction reaction. 51 The hole can prompt electrons from hydroxyl ions and/or water to OH formation due to an oxidative reaction. 59 Quantitative differences of ROS induced by the same nanomaterial are due to the differences in characters of the nanoparticles (e.g., sources, synthetic techniques, size, shape, and concentration) and experimental settings (e.g., ionic power and pH of the solution and use of light illumination).
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ROS formation induced by antibiotics
Several corresponding studies have reported that ROS production and oxidative stress are associated with the drug lethality of some antimicrobial agents. ROS have been involved in antibiotic-mediated lethality, but the causal mechanisms of this influence remain uncertain. Recently, it has been reported that major groups of bactericidal agents, regardless of their drug-target interactions, prompt a common oxidative destruction of cellular targets in organisms, primarily by creating toxic ROS through the interference of the tricarboxylic acid pathway and the electron transport chain. [60] [61] [62] Several bactericidal agents, such as β-lactams, quinolones, and aminoglycosides, can induce ROS generation, which are highly damaging molecules that can inhibit most functions of oxygen-respiring cells (Figure 2) . 63 The general process of toxic OH
• generation involves the tricarboxylic acid pathway and a transient depletion of NADH, as well as iron-sulfur cluster instability and disturbance of iron regulation. 11 Production of high levels of OH • may be the common mechanism for antimicrobial-mediated lethality. 64 Antimicrobial agents enhance the generation of O 2 − , which then enzymatically converts to peroxide, from which an extremely damaging • OH is produced. Then,
• OH increases the bactericidal effects. 64 The bactericidal effects of antimicrobial agents are decreased under strict anaerobic environments, but they could be increased by the addition of O 2 or by exposure to another electron receptor, demonstrating that the environmental condition is a remarkable factor in the efficiency of antimicrobial agents. The overproduction of catalase or DNA repair system enzymes, MutS (a DNA 
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Antimicrobial use of reactive oxygen therapy mismatch repair protein), and the pre-exposure to antioxidants restrict antibiotic bactericidal effects, suggesting that ROS may play a critical role in antimicrobial agent lethality. 65 The absence of sodA or sodB had no significant influence on norfloxacin's bactericidal effects; however, the deficiency of both genes together limited the killing effects, which was dependent on a quick conversion of inordinate levels of O 2 − to H 2 O 2 , contributing to the quinolone bactericidal effects. Norfloxacin is more effective with the mutant absence of katG than with its isogenic source, indicating that detoxification of peroxide to water typically decreases quinolone efficiency. 64 
Photodynamic therapy (PDT)
PDT is a method based on ROS generation to cause the inactivation of eukaryote or prokaryote cells using a nontoxic dye known as the photosensitizer (PS) molecule in the presence of low strength visible light. 66, 67 The photodynamic inactivation of organisms is based on the idea that a PS should be localized selectivity in the target organism and not in the surrounding tissues or cells, and subsequently excited by low doses of visible light with a suitable wavelength (Figure 3) . The stimulated PS transfers energy or electrons to the ground state molecular O 2 , producing ROS such as a singlet oxygen ( 1 O 2 ) and
• OH that are toxic to target organisms. 68, 69 The microbial selectivity of PDT has been described as the result of the different pharmacokinetics of eukaryotes and bacterial cells rather than due to specific molecular targets. 70 The specificity of PDT is assisted by the condition that 1 O 2 , the chief antibacterial type, has a limited half-life and a narrow diffusion dimension at a wavelength of 100 nm. 70 The interactions of the motivated PS are by a Type I or a Type II procedure. The Type I procedure is the reaction of an ē transfer from the PS triplet state, which affects the generation of ROS including 
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Memar et al have been observed to be due to the destruction of nucleic acid and/or the cytoplasmic membrane. 71 PDT also inhibits the toxic effects of endotoxins such as lipopolysaccharides. 72 Some studies have described PDT as less effective against Gram-negative bacteria due to its lower permeability to certain PS such as curcumin. 72, 73 Phototherapeutically increased spectra have been described by the synergistic effect of mesoporous silica trio-nanohybrids against antibiotic-resistant Gram-negative bacteria. This increased efficiency may be due to the positively charged modified PS and, thus, the increased antimicrobial response through greater affinity to the bacterial cell membrane. 72 PDT offers considerably more advantages over traditional antibacterial agents. It has antibacterial effects against multidrugresistant isolates, which has an effect significantly quicker than traditional agents.
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Hyperbaric oxygen treatment
Hyperbaric oxygen therapy (HBOT) is a treatment method for soft tissue infections. 75 HBOT is a systemic method conducted in a pressurized chamber where the patient inhales 100% O 2 for a specified time in which it is delivered by the lung to the whole body. 76, 77 HBOT induces the release of ROS and eliminates the optimum conditions required for obligate and facultative anaerobic bacteria that lack antioxidant defense mechanisms. 38 The ROS released during HBOT are destructive for DNA and other biologic molecules (Figure 4) . 78 HBOT at a pressure greater than 2 ATA has been shown to have an antibacterial effect against some facultative anaerobic bacteria and aerobic bacteria. 79, 80 HBOT enhances the antibacterial effects of some antibiotics such as imipenem and tobramycin. 79, 81 However, HBOT has been reported to not intensify the antimicrobial effect of distamycin and rifampicin. 82 The combination therapy of ciprofloxacin and HBOT may be potentially beneficial for the eradication of infections caused by the biofilm forming Pseudomonas aeruginosa. 83, 84 Other than being a direct bactericidal, HBOT enhances the bactericidal mechanisms of impaired host immunity, particularly polymorphonuclear leukocytes, due to wound tissue hypoxia. 85 HBOT is used as a primary or alternative method for the treatment of infections such as diabetic foot infection, 76, 86 surgical site infections, 87 gas gangrenes, 88 osteomyelitis, 89 and necrotizing facilities. 87, 90 In addition to the bactericidal effects, HBOT suppresses the production of clostridia alpha toxin in gas gangrene disease.
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Honey therapy
Honey has been reported to be an effective treatment for wound care due to its antimicrobial effects and healing properties. 92 The antimicrobial activity of honey is believed to be attributable to its physical properties such as low pH, high osmolality, and the presence of high sugar levels and the antimicrobial components of certain types of honey, such as bee defensin-1 and hydrogen peroxide, and the induction of H 2 O 2 generation. 91, 92 There are many types of therapeutic honey in the market (e.g., Paterson's curse, Rosemary, Manuka, Thyme, Revamil, Rewa Rewa, heather honey, Khadi Kraft honey, Multifloral, and Medihoney). 93, 94 Surgihoney RO (SH1) is an approved sterilized honey derived from natural organic honey from different origins. SH1 has been produced 
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Antimicrobial use of reactive oxygen therapy as a preventive antimicrobial agent for soft tissue infections. It has been designed by a specific engineering procedure to exert high levels of antimicrobial effects due to ROS generation ( Figure 4 ). Subsequently, ROS induce oxidative stress due to
• OH production and inhibit the essential metabolic procedure for bacterial growth. 91 The main antimicrobial activities of SH1 and two modified prototypes, PT1 and PT2, are due to the ROS hydrogen peroxide. 92 In addition to SH1, other formulated prototypes (PT1 and PT2) were designed to increase the generation of H 2 O 2 . This indicates that antimicrobial effects may be applied at an increased potency if desired. 91, 92 This ROS-inducing mechanism provides significant antimicrobial properties that are optimally applicable for the prophylaxis of acute or chronic infections through a honey dressing. 92 Lower levels of catalase are present in wounds. 95 It has been reported that catalase levels in healing wounds decrease significantly the first week after the wound is caused and regain their normal activity during the 2 weeks following the injury. 96 These levels of catalase are, therefore, uncertain to affect the antimicrobial effects induced by exogenously applied SH1 or the two modified prototypes, PT1 and PT2.
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Biofilm eradication by ROS-forming procedures
Biofilms are dense layers of microbial communities attached to different surfaces. 97 Bacteria in biofilm environments express character differently than planktonic forms, for example, decreased susceptibility to antimicrobial agents. Therefore, biofilms may act as a niche for the recurrence of infections. These infections can remain for months, years, or even a lifetime. It has been estimated that 65% of the hospitalacquired infections are caused by biofilm forms of microbial growth. 98, 99 Therefore, the development of antibiofilm methods is critical for the management and control of infection, especially in hospital environments. The antibiofilm activity of SH1 has been reported against biofilm-producing bacteria that may cause wound infection. 91 It has been reported that the reoxygenation of anoxic P. aeruginosa biofilm by HBOT increases the bactericidal effects of ciprofloxacin, likely by engaging the aerobic metabolic procedure and resulting in decreased resistance to an antimicrobial agent. Thus, HBOT may be applicable to enhance the effect of antibiotic treatment of infections caused by biofilm-producing organisms. 84 However, the role of ROS generation as a direct mechanism of antibiofilm activity in these methods needs to be further studied.
Future aspects
ROS is an effective option for eradicating microbial pathogens. ROS can be induced by a wide variety of procedures. Some of these methods are old and traditional, such as antibiotics, HBOT, and PDT. The increased frequency of antibioticresistant pathogens and the limited options for treatment may encourage the reappearance of attention to the use of these methods. Nanomaterials and engineered medical honey are rather novel methods which can induce ROS formation in microbial cells. Nevertheless, such methods may induce ROS formation in host cells. Therefore, the future development of delivery strategies for increasing the selectivity of ROS for microbial pathogens over the host tissue may make possible the clinical use of ROS. The suppression of host microflora by induced ROS and the economic issues should also be investigated in future studies.
Conclusion
ROS are molecules effective in inhibiting clinically important microbial pathogens, and they are an attractive option for the treatment of infections. ROS are produced intracellularly as an alternative metabolite due to some biologic pathways; they are also inducible by several artificial exogenous procedures. Certain traditional bactericidal antibiotics and nanomaterials induce ROS as an alternative or a main mechanism of antibacterial effects. HBOT, medical honey, and PDT are other procedures that inhibit microbial growth by forming ROS. These procedures are commonly applied for the treatment or prevention of soft tissue infections, but not for systemic infections. The development of resistance to these methods has not been reported, but selectivity for microbial targets other than host cells and microflora requires further studies. ROS also have a destructive effect on eukaryotes that limits their clinical application as an antimicrobial agent. The clinical application of ROS for infections requires much further research, considering the degenerative circumstances in eukaryotes due to oxidative stress. Identifying the delivery techniques for using ROS with the favorable selectivity of microbial pathogens and without any effects on the host tissue may be potential treatment method for a wide range of infections, especially those caused by drug-resistant organisms.
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